AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) announced it will report its financial results for Q2 of fiscal year 2023 on January 5, 2023, before the market opens. A conference call with management will be held at 8:00 a.m. ET to discuss these results. Investors can participate by dialing 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and using the passcode 13734978. The call will also be webcast on the AngioDynamics website, with a replay available shortly after the call concludes.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the second quarter of fiscal year 2023 before the market open on Thursday, January 5, 2023. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13734978.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Thursday, January 5, 2023, until 11:59 p.m. ET on Thursday, January 12, 2023. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13734978.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221215006035/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its Q2 2023 financial results?

AngioDynamics will report its Q2 2023 financial results on January 5, 2023.

What time is the conference call for AngioDynamics Q2 results?

The conference call for AngioDynamics Q2 results will be at 8:00 a.m. ET on January 5, 2023.

How can I participate in the AngioDynamics Q2 results conference call?

You can participate by calling 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and using the passcode 13734978.

Will there be a webcast for the AngioDynamics Q2 results?

Yes, the conference call will be webcast and can be accessed from the Investors section of the AngioDynamics website.